Days after the Food and Drug Administration’s (FDA) approval of a generic version of Actos (pioglitazone), consumer advocacy group Consumer Reports released a statement claiming that the risks of using pioglitazone far outweigh its benefits.
The group asks customers to avoid Actos and its generics unless other treatments have failed them, citing the drug’s dangerous side effects, which include increased risk of heart failure and bladder cancer.
Consumer Reports recommends diabetes patients use metformin instead of drugs that contain pioglitazone.
If you have taken Actos as directed and developed bladder cancer, there is a strong chance that the two are related. Contact the Actos lawsuit attorneys of Williams Kherkher at 800-641-9810 to learn more about how an Actos lawyer can help you seek compensation for your medical costs and other bladder cancer-related expenses.